Anti-IFN gamma Receptor beta/AF-1 antibody [EPR8813] - BSA and Azide free
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(2 Publications)
Rabbit Recombinant Monoclonal IFN gamma Receptor beta/AF-1 antibody. Carrier free. Suitable for WB and reacts with Human samples. Cited in 2 publications.
View Alternative Names
IFNGT1, IFNGR2, Interferon gamma receptor 2, IFN-gamma receptor 2, IFN-gamma-R2, Interferon gamma receptor accessory factor 1, Interferon gamma receptor beta-chain, Interferon gamma transducer 1, AF-1, IFN-gamma-R-beta
- WB
Supplier Data
Western blot - Anti-IFN gamma Receptor beta/AF-1 antibody [EPR8813] - BSA and Azide free (AB249636)
This data was developed using ab171081, the same antibody clone in a different buffer formulation.
All lanes:
Western blot - Anti-IFN gamma Receptor beta/AF-1 antibody [EPR8813] (<a href='/en-us/products/primary-antibodies/ifn-gamma-receptor-beta-af-1-antibody-epr8813-ab171081'>ab171081</a>) at 1/1000 dilution
Lane 1:
Fetal heart tissue lysate at 10 µg
Lane 2:
Human skeletal muscle tissue lysate at 10 µg
Lane 3:
Fetal thymus tissue lysate at 10 µg
Predicted band size: 38 kDa
false
Related conjugates and formulations (1)
-
Anti-IFN gamma Receptor beta/AF-1 antibody [EPR8813]
Reactivity data
Product details
ab249636 is the carrier-free version of ab171081.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
IFN gamma Receptor beta is essential for the activation of the immune system. It partners with IFN gamma Receptor alpha in the receptor complex to mediate important biological effects such as activation of macrophages and enhancement of antigen presentation. This activity boosts the cellular immune response allowing cells to better combat microbial infections and tumor growth. Without functional receptor activity cells would not effectively respond to IFN-gamma signals impeding proper immune function.
Pathways
IFN gamma Receptor beta is involved in the JAK-STAT signaling pathway which is important for mediating IFN-gamma signaling. Once IFN-gamma binds to its receptor including the beta chain it triggers the activation of JAK kinases which in turn phosphorylates STAT1. Phosphorylated STAT1 dimerizes translocates to the nucleus and influences the expression of immune regulatory genes. This pathway connects the receptor with key immune regulatory proteins playing an important role in the immune response.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
Clinical and experimental pharmacology & physiology 52:e70032 PubMed40069996
2025
Applications
Unspecified application
Species
Unspecified reactive species
Bio-protocol 15:e5206 PubMed39959296
2025
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com